Recently Viewed

News Announcement

Shilpa Medicare: Announcement under Regulation 30 (LODR)-Press Release / Media Release

11-Sep-2026 Follow Value Research Online on Google download pdfDownload PDF Shilpa Medicare

Shilpa Medicares Novel Complex Injectable OERIS (Ondansetron Extended - Release Injection 100 mg/mL) receives final approval from Subject Expert Committee (SEC) for grant of marketing authorization.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan